Additional file 1 of [225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer

Figshare 2026 Open access

Read full text
Authors: Anjong Florence Tikum, Dede Api Fon, Fabrice Ngoh Njotu, Nikita W. Henning, Emmanuel Nwangele, Hanan Babeker, Jessica Pougoue Ketchemen, Alireza Doroudi, Maruti Uppalapati, Humphrey Fonge
DOI: 10.6084/m9.figshare.31311238
Cited by: 0

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Chemical Reactions and Isotopes HER2/EGFR in Cancer Research

Publication details

Journal / source
Figshare
Publication date
1 January 2026
Language
EN